Use of a 2-Dimensional Ionization Chamber Array to Measure Head Leakage of a Varian Truebeam^®Linear Accelerator

The purpose of this work is to evaluate the use of a two-dimensional (2D) planar ion chamber array to characterize leakage radiation from the head of the linear accelerator. Ion chamber arrays provide a benefit over a singular ion chamber measurement as they allow for the measurement of a larger area in order to isolate the point of maximum leakage dose and the small size of each individual ion chamber minimizes volume-averaging effects. A Varian Truebeam® undergoing acceptance testing was used for all measurements. The gantry was wrapped in Portal Pack for Localization (PPL) radiographic film in order to isolate the location of maximum leakage. A calibration curve was developed and used to determine dose-to-film. An Ion Chamber Profiler (IC Profiler™) manufactured by Sun Nuclear Corporation was used to confirm measurements by the PPL film. All measurements were normalized to leakage at 100 cm from the target relative to the central axis. Three points were investigated with the IC Profiler, including the top of the gantry, the Varian logo, and the side of the gantry. For the three locations, respectively, the PPL film and the IC profiler were measured 0.142% and 0.131%, 0.036% and 0.030%, and 0.014% and 0.019%. The good agreement between the PPL film and the IC Profiler provides confidence in the use of a more efficient and accurate ion chamber array for head leakage measurements.

Validation of Treatment Planning Dose Calculations: Experience Working with Medical Physics Practice Guideline 5.a.

Recently published Medical Physics Practice Guideline 5.a. (MPPG 5.a.) by American Association of Physicists in Medicine (AAPM) sets the minimum requirements for treatment planning system (TPS) dose algorithm commissioning and quality assurance (QA). The guideline recommends some validation tests and tolerances based primarily on published AAPM task group reports and the criteria used by IROC Houston. We performed the commissioning and validation of the dose algorithms for both megavoltage photon and electron beams on three linacs following MPPG 5.a. We designed the validation experiments in an attempt to highlight the evaluation method and tolerance criteria recommended by the guideline. It seems that comparison of dose profiles using in-water scan is an effective technique for basic photon and electron validation. IMRT/VMAT dose calculation is recommended to be tested with some TG-119 and clinical cases, but no consensus of the tolerance exists. Extensive validation tests have provided the better understanding of the accuracy and limitation of a specific dose calculation algorithm. We believe that some tests and evaluation criteria given in the guideline can be further refined.